Removing One Barrier to Protecting Sex Partners in HIV Remission Studies With a Treatment Interruption.
Where this comes from
- Record sourced from PubMed, PMID 31264690.
- Also identified by DOI 10.1093/infdis/jiz162 and PMC identifier 6603972.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Only a few of the recommendations made in this supplement are implemented in ongoing HIV remission studies that involve an analytical treatment interruption. The absence of these recommendations in protocols puts sexual partners of study participants at serious risk. This paper addresses one possible barrier to implementation: a certain misunderstanding among sponsors and research entities.
Medical subject headings
- Anti-HIV Agents
- Coinfection
- HIV Infections
- Sexual Partners
- Unsafe Sex
- Vaccines